Clinical Trial of Entecavir/Pegylated Interferon in Immunotolerant Children With Chronic HBV Infection (HBRN)
Phase of Trial: Phase III
Latest Information Update: 11 Jul 2018
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Acronyms HBRN IT Peds
- 23 Aug 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
- 29 Aug 2016 Planned End Date changed from 1 Sep 2017 to 1 Nov 2016.